Keywords
Wheezing
Acute Disease
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: Analyze the characteristics of Acute Viral Bronchiolitis (AVB) and discuss its appropriate treatment. Literature review: AVB is a common condition, especially in children under the age of two. It manifests itself through a wide variety of symptoms, affecting both the lower and upper airways. Among these symptoms, wheezing, hypoxemia, thoracic retractions and other symptoms indicative of respiratory distress stand out. Its pathophysiology involves an inflammatory response in the airways, resulting in excessive mucus production and failure to clear it. Final considerations: AVB is a frequent lung disease in pediatric outpatient clinics. Its diagnosis is based predominantly on the clinical manifestations and physical examination of the patient. As for the treatment, there is debate about the use of some specific medications, but it is essential to emphasize that the current treatment should be strictly supportive. Therefore, it is of paramount importance to know about AVB so that the professional, when faced with the disease, performs the management, avoiding complications and unfavorable results.
References
ANGURANA SK, et al. Acute Viral Bronchiolitis: A Narrative Review. Journal of Pediatric Intensive Care, 2023; 12(2): 79–86.
BARALDI E, et al. RSV disease in infants and young children: Can we see a brighter future? Human Vaccines & Immunotherapeutics, 2022; 18(4): 2079322.
BARR R, et al. Respiratory syncytial virus: diagnosis, prevention and management. Therapeutic Advances in Infectious Disease, 2019; 6: 2049936119865798.
BIAGI C, et al. Rhinovirus Infection in Children with Acute Bronchiolitis and Its Impact on Recurrent Wheezing and Asthma Development. Microorganisms, 2020; 8(10): 1620, 2020.
BUENDÍA JA, et al. Systematic review and meta-analysis of efficacy and safety of continuous positive airways pressure versus high flow oxygen cannula in acute bronchiolitis. BMC Pediatrics, 2022; 22(1): 696.
CAI Z, et al. Efficacy of salbutamol in the treatment of infants with bronchiolitis: A meta-analysis of 13 studies. Medicine, 2020; 99(4): e18657.
DAFYDD C, et al. Efficacy and safety of high flow nasal oxygen for children with bronchiolitis: systematic review and meta-analysis. BMJ open respiratory research, 2021; 8(1): e000844.
DALL’OLIO CC, et al. Tratamento da bronquiolite viral aguda. Residência Pediatrica, 2021; 11(3): 1–5.
DE ÁVILA KFOURI R, et al. Diretrizes para o manejo da infecção causada pelo vírus sincicial respiratório (VSR) - 2017. 2017.
DE VIGILÂNCIA EM SAÚDE E AMBIENTE, M. DA S. S. NOTA TÉCNICA No 30/2023-CGVDI/DPNI/SVSA/MS. Disponível em:<https://www.gov.br/saude/pt-br/centrais-de-conteudo/public
acoes/notas-tecnicas/2023/nota-tecnica-no-30-2023-cgvdi-dpni-svsa-ms. Acessado em: 20 de setembro de 2023.
DUMAS O, et al. Severe bronchiolitis profiles and risk of asthma development in Finnish children. Journal of Allergy and Clinical Immunology, 2022; 149(4): 1281-1285.e1.
FALAHI S, et al. The prevalence of human bocavirus in <2-year-old children with acute bronchiolitis. New Microbes and New Infections, 2020; 37: 100736.
GHAZALY MMH, et al. Acute viral bronchiolitis as a cause of pediatric acute respiratory distress syndrome. European Journal of Pediatrics, 2021; 180(4): 1229–1234.
KUITUNEN I, et al. Helium-oxygen in bronchiolitis-A systematic review and meta-analysis. Pediatric Pulmonology, 2022; 57(6): 1380–1391.
JARTTI T, et al. Bronchiolitis needs a revisit: Distinguishing between virus entities and their treatments. Allergy, 2019; 74(1): 40–52.
JAT KR, et al. Continuous positive airway pressure (CPAP) for acute bronchiolitis in children. The Cochrane Database of Systematic Reviews, 2022; 4(4): CD010473.
JIMÉNEZ GARCÍA R, et al. Impact of a new acute bronchiolitis protocol on clinical practice. Anales De Pediatria, 2019; 90(2): 79–85.
KENMOE S, et al. Systematic review and meta-analysis of the prevalence of common respiratory viruses in children < 2 years with bronchiolitis in the pre-COVID-19 pandemic era. PloS One, 2020; 15(11): e0242302.
MANTI S, et al. UPDATE - 2022 Italian guidelines on the management of bronchiolitis in infants. Ital J Pediatr., 2023; 49: 19.
OZUNA S, et al. Factores clínicos y socioeconómicos asociados a bronquiolitis severa en lactantes menores de 24 meses. Estudio de caso control. Pediatría (Asunción), 2022; 49(3): 154–161.
PORCARO F, et al. Bronchiolitis guidelines: what about the Italian situation in a primary care setting? Ital J Pediatr., 2023; 49(1): 123.
RECOMENDACIONES PARA EL MANEJO DE LAS INFECCIONES RESPIRATORIAS AGUDAS BAJAS EN MENORES DE 2 AÑOS. Actualización 2021. Archivos Argentinos de Pediatria, 2021; 119(4).
VAUX S, et al. Bronchiolitis epidemics in France during the SARS-CoV-2 pandemic: The 2020-2021 and 2021-2022 seasons. Infectious Diseases Now, 2022; 52(6): 374–378.
VEGA-BRICEÑO LE. Actualización de la bronquiolitis aguda. Neumol. pediátr. (En línea), 2021; 69–74.
YU JF, et al. 3% nebulized hypertonic saline versus normal saline for infants with acute bronchiolitis: A systematic review and meta-analysis of randomized controlled trials. Medicine, 2022; 101(43): e31270.